Divergent trial results on cancer vaccines have field grappling with hard questions
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
Eli Lilly’s Zepbound plus amylin drug led to major weight loss in mid-stage trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
GLP-1s in children, Syntis Bio, Vera: Readout Newsletter
National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
The VA is critical to winning the biotech race with China
Biotechnology is rapidly becoming a pillar of national power. The nation that can discover, test, and deploy new…
FDA questions the efficacy of Capricor’s Duchenne drug
The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell treatment for Duchenne muscular dystrophy did…
Measles Is Becoming So Common That Treatments May Soon Be Needed
“I think this is a real opportunity to solve a public health problem,” Saphire says. “A tool by…
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
Bristol Myers buys Nvidia’s latest AI computing system for drug research
By Michael Erman NEW YORK, July 20 (Reuters) – Bristol Myers Squibb said on Monday it is buying…